MetaVia Inc. (MTVA) shareholders
MTVANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.30+0.00 (0.00%)
Close on Nov 13, 2026Market cap $8.56MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
4.4%
0M of 7M shares
Institutional holders
17
5 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Dong-A ST Co., Ltd. Joint filing with Dong-A Socio Holdings Co., Ltd. (24.70%) | 9,995,679 | 51.10% | 13D (active) amendment | May 8, 2025 |
| Steven Boyd Joint filing with Armistice Capital, LLC (9.99%) | 902,248 | 9.99% | 13G (passive) amendment | Mar 31, 2025 |
| Alyeska Investment Group, L.P. Joint filing with Alyeska Fund GP, LLC (9.99%), Anand Parekh (9.99%) | 508,585 | 9.99% | 13G (passive) | Mar 31, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of MTVA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 123,583 | 1.88% | $176.72K | +112,680 | 0.00% |
| Citadel Advisors LLC | 61,206 | 0.93% | $87.53K | New | 0.00% |
| Virtu Financial LLC | 29,933 | 0.45% | $43.00K | New | 0.00% |
| Geode Capital Management, LLC | 21,314 | 0.32% | $30.48K | −12,321 | 0.00% |
| UBS Group AG | 12,948 | 0.20% | $18.52K | +12,947 | 0.00% |
| Scientech Research LLC | 12,014 | 0.18% | $17.18K | New | 0.01% |
| Aries Wealth Management | 10,000 | 0.15% | $14.30K | – | 0.00% |
| Vanguard Capital Management LLC | 8,919 | 0.14% | $12.75K | +6,697 | 0.00% |
| Vanguard Fiduciary Trust Co | 6,940 | 0.11% | $9.92K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 2,223 | 0.03% | $3.18K | −379 | 0.00% |
| SBI Securities Co., Ltd. | 270 | 0.00% | $386 | +65 | 0.00% |
| Morgan Stanley | 10 | 0.00% | $14 | New | 0.00% |
| BlackRock, Inc. | 7 | 0.00% | $10 | −472 | 0.00% |
| Caitong International Asset Management Co., Ltd | 3 | 0.00% | $4 | – | 0.00% |
| Brown Brothers Harriman & Co | 2 | 0.00% | $3 | – | 0.00% |
| International Assets Investment Management, LLC | 2 | 0.00% | $3 | New | 0.00% |
| Danske Bank A/S | 2 | 0.00% | $3 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 17 | 0M | 4.4% | 5 / 4 | 3 / 0 | 0M | 0M |
| Q1 2026 | 12 | 0M | 1.0% | 6 / 2 | 1 / 4 | 0M | 0M |
| Q4 2025 | 11 | 0M | 0.6% | 4 / 4 | 1 / 9 | 0M | 0M |
| Q3 2025 | 16 | 0M | 0.6% | 4 / 6 | 1 / 3 | 0M | 0M |
| Q2 2025 | 15 | 0M | 0.4% | 3 / 5 | 1 / 2 | 0M | 0M |
| Q1 2025 | 14 | 0M | 1.0% | 0 / 4 | 2 / 1 | 0M | 0M |
| Q4 2024 | 15 | 0M | 1.3% | 4 / 2 | 3 / 2 | 0M | 0M |
| Q3 2024 | 13 | 0M | 1.5% | 3 / 5 | 1 / 1 | 0M | 0M |
| Q2 2024 | 12 | 0M | 1.2% | 2 / 3 | 3 / 3 | 0M | 0M |
| Q1 2024 | 13 | 0M | 0.1% | 6 / 2 | 1 / 1 | 0M | 0M |
| Q4 2023 | 8 | 0M | 0.1% | 8 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
4 funds held MTVA in Q2 2026, 9% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of MTVA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 20,350 | 0.31% | $57.79K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 2,222 | 0.03% | $3.18K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 431 | 0.01% | $1.22K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 431 | 0.01% | $1.22K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Hyung Heon Kim | CEO & President, Director | 37,545 | 0.57% | Jan 27, 2026 |
| Sarah Kaplan Browne | Chief Medical Officer | 53,000 | 0.80% | Oct 13, 2026 |
| Marshall H. Woodworth | Chief Financial Officer | 30,734 | 0.47% | Jan 27, 2026 |
| Michael Salsbury | Director | 21,338 | 0.32% | Jun 8, 2026 |
| Jason L. Groves | Director | 21,338 | 0.32% | Jun 8, 2026 |
| D. Gordon Strickland | Director | 21,339 | 0.32% | Jun 8, 2026 |
| Mark A. Glickman | Director | 20,629 | 0.31% | Jun 8, 2026 |
| Andrew I. Koven | Director | 21,339 | 0.32% | Jun 8, 2026 |
| James Patrick Tursi | Director | 20,568 | 0.31% | Jun 8, 2026 |
| Dong-A St Co., Ltd | 10% owner | 9,995,679 | 151.72% | May 20, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Sarah Kaplan Browne Chief Medical Officer | Oct 12, 2026 | Award | +53,000 | – | – | 53,000 |
| Michael Salsbury Director | Jun 8, 2026 | Award | +17,186 | – | – | 21,338 |
| Andrew I. Koven Director | Jun 8, 2026 | Award | +17,186 | – | – | 21,339 |
| Jason L. Groves Director | Jun 8, 2026 | Award | +17,186 | – | – | 21,338 |
| Mark A. Glickman Director | Jun 8, 2026 | Award | +17,186 | – | – | 20,629 |
| James Patrick Tursi Director | Jun 8, 2026 | Award | +17,186 | – | – | 20,568 |
| D. Gordon Strickland Director | Jun 8, 2026 | Award | +17,186 | – | – | 21,339 |
| Marshall H. Woodworth Chief Financial Officer | Jan 23, 2026 | Award | +28,000 | – | – | 30,734 |
| Hyung Heon Kim CEO & President, Director | Jan 23, 2026 | Award | +32,000 | – | – | 37,545 |
| Marshall H. Woodworth Chief Financial Officer | Aug 12, 2025 | Gift | −14,200 | – | – | 30,079 |
| James Patrick Tursi Director | Jun 30, 2025 | Award | +28,147 | – | – | 37,219 |
| Andrew I. Koven Director | Jun 30, 2025 | Award | +28,147 | – | – | 45,699 |
| Jason L. Groves Director | Jun 30, 2025 | Award | +28,147 | – | – | 45,699 |
| D. Gordon Strickland Director | Jun 30, 2025 | Award | +28,147 | – | – | 45,699 |
| Michael Salsbury Director | Jun 30, 2025 | Award | +28,147 | – | – | 45,699 |
| Mark A. Glickman Director | Jun 30, 2025 | Award | +28,147 | – | – | 37,887 |
| Marshall H. Woodworth Chief Financial Officer | Jun 4, 2025 | Buy | +14,200 | $0.70 | $9.94K | 44,279 |
| Dong-A St Co., Ltd 10% owner | May 8, 2025 | Buy | +4,647,887 | $0.71 | $3.30M | 9,995,679 |
| Marshall H. Woodworth Chief Financial Officer | Mar 1, 2025 | Tax withholding | −3,417 | $1.46 | $4.99K | 30,079 |
| Hyung Heon Kim CEO & President, Director | Mar 1, 2025 | Tax withholding | −2,795 | $1.46 | $4.08K | 61,004 |
| Hyung Heon Kim CEO & President, Director | Nov 30, 2024 | Tax withholding | −2,867 | $2.55 | $7.31K | 63,799 |
| Dong-A St Co., Ltd 10% owner | Sep 12, 2024 | Sale | −407 | $3.75 | $1.53K | 5,347,792 |
| Hyung Heon Kim CEO & President, Director | Aug 11, 2024 | Tax withholding | −11,467 | $3.60 | $41.28K | 66,666 |
| Dong-A St Co., Ltd 10% owner | Jun 23, 2024 | Buy | +2,544,530 | $3.93 | $10.00M | 5,348,229 |
| Dong-A St Co., Ltd 10% owner | Jun 23, 2024 | Buy | +2,544,530 | $3.13 | $7.96M | 5,348,229 |
| Jason L. Groves Director | Jun 7, 2024 | Award | +5,051 | – | – | 17,552 |
| Michael Salsbury Director | Jun 7, 2024 | Award | +5,051 | – | – | 17,552 |
| Mark A. Glickman Director | Jun 7, 2024 | Award | +5,051 | – | – | 9,740 |
| Andrew I. Koven Director | Jun 7, 2024 | Award | +5,051 | – | – | 17,552 |
| James Patrick Tursi Director | Jun 7, 2024 | Award | +5,051 | – | – | 9,072 |
| D. Gordon Strickland Director | Jun 7, 2024 | Award | +5,051 | – | – | 17,552 |
| Marshall H. Woodworth Chief Financial Officer | Mar 1, 2024 | Award | +33,496 | – | – | 33,496 |
| James Patrick Tursi Director | Dec 1, 2023 | Award | +7,157 | – | – | 32,157 |
| James Patrick Tursi Director | Dec 1, 2023 | Award | +25,000 | – | – | 25,000 |
| Hyung Heon Kim CEO & President, Director | Aug 11, 2023 | Award | +625,064 | – | – | 625,064 |
| Mark A. Glickman Director | Jul 27, 2023 | Award | +25,000 | – | – | 25,000 |
| Mark A. Glickman Director | Jul 27, 2023 | Award | +12,500 | – | – | 37,500 |
| D. Gordon Strickland Director | Jul 27, 2023 | Award | +87,500 | – | – | 87,500 |
| D. Gordon Strickland Director | Jul 27, 2023 | Award | +12,500 | – | – | 100,000 |
| Na Yeon Kim Director, 10% owner | Jul 27, 2023 | Award | +87,500 | – | – | 88,959 |
| Na Yeon Kim Director, 10% owner | Jul 27, 2023 | Award | +12,500 | – | – | 101,459 |
| Michael Salsbury Director | Jul 27, 2023 | Award | +12,500 | – | – | 100,000 |
| Michael Salsbury Director | Jul 27, 2023 | Award | +87,500 | – | – | 87,500 |
| Andrew I. Koven Director | Jul 27, 2023 | Award | +12,500 | – | – | 100,000 |
| Andrew I. Koven Director | Jul 27, 2023 | Award | +87,500 | – | – | 87,500 |
| Jason L. Groves Director | Jul 27, 2023 | Award | +87,500 | – | – | 87,500 |
| Jason L. Groves Director | Jul 27, 2023 | Award | +12,500 | – | – | 100,000 |
| Na Yeon Kim Director, 10% owner | Jul 26, 2022 | Other | +4,671 | – | – | 4,671 |
| Na Yeon Kim Director, 10% owner | Jul 26, 2022 | Other | −1,445,267 | – | – | 2,890,533 |
| Investment Fund E&Healthcare II 10% owner | Jul 26, 2022 | Other | −1,445,267 | – | – | 2,890,533 |
| Akash Bakshi SVP and COO, Director | Dec 31, 2020 | Award | +855,059 | – | – | 884,072 |
| Akash Bakshi SVP and COO, Director | Dec 31, 2020 | Award | +29,013 | – | – | 29,013 |
| Na Yeon Kim Director, 10% owner | Dec 30, 2019 | Award | +1,121,190 | – | – | 1,121,190 |
| Na Yeon Kim Director, 10% owner | Dec 30, 2019 | Award | +4,335,800 | – | – | 4,335,800 |
| Na Yeon Kim Director, 10% owner | Dec 30, 2019 | Award | +1,864,799 | – | – | 1,864,799 |
| Jeong Gyun Oh Director, 10% owner | Dec 30, 2019 | Award | +240,051 | – | – | 240,051 |
| Jeong Gyun Oh Director, 10% owner | Dec 30, 2019 | Award | +1,817,842 | – | – | 1,817,842 |
| Charles Bisgaier PhD Chief Scientific Off. & Chair, Director, 10% owner | Jul 24, 2019 | Award | +100,000 | – | – | 1,348,914 |
| Pedro Lichtinger Director | Jul 24, 2019 | Award | +15,000 | – | – | 74,833 |
| Kenneth W. Kousky Director | Jul 24, 2019 | Award | +15,000 | – | – | 26,935 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
0.85%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-43.2%
From 0M shares
Short volume, 20 days
50.2%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of MetaVia's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,637 shares on Sep 4, 2026 over the last 90 days.
See a number that looks wrong?